MTNB stock

Matinas BioPharma Holdings Inc (MTNB) financials · $5.6M cap

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Matinas BioPharma Holdings Inc (MTNB) $5.6M cap.

Cached annual income statement
LineFY2025FY2024
Operating Income-$6.96M-$24.6M
Net Income-$10.3M-$24.3M
EPS (Diluted)N/A-$4.98
Cached annual balance sheet
LineFY2025FY2024
Total Assets$7.21M$12.6M
Current Assets$4.08M$8.03M
Cash & Equivalents$4.00M$7.28M
PP&E$138.0K$468.0K
Total Liabilities$2.38M$5.05M
Current Liabilities$1.46M$2.67M
Shareholders' Equity$4.83M$7.59M
Retained Earnings-$210.8M-$199.8M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$7.01M-$15.9M
Investing Cash Flow$335.0K$9.21M
Financing Cash Flow$3.39M$9.17M
Net Change in Cash-$3.29M$2.50M
These statements as JSON? API free 100/day

FAQ

What is MTNB P/E and revenue?

Matinas BioPharma Holdings Inc (MTNB) $5.6M cap.

What is MTNB revenue?

MTNB income-statement cache has no revenue figure yet.

Is MTNB profitable?

Matinas BioPharma Holdings Inc last cached net income is -$10.3M (FY2025).

What are MTNB total assets?

Matinas BioPharma Holdings Inc last cached total assets are $7.21M (FY2025).

What is MTNB free cash flow?

No cached cash-flow row for MTNB yet.

Not investment advice. Cached statements, not a live tape.